Back to company

UNIPHARMA ApS: Financial statements 2019

CVR: 78881917

UNIPHARMA ApS (CVR 78881917) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK -5,000 and a net result of DKK -5,000 compared with DKK -10,140 the year before. Equity amounted to DKK 66,735. The solvency ratio was 37%.

Revenue
-5,000 kr.
Gross Profit
-5,000 kr.
Profit/Loss
-5,000 kr.
Equity
66,735 kr.
Total Assets
180,490 kr.

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2019-5 t.-5 t.-5 t.67 t.-
2018-10 t.-10 t.-10 t.72 t.-
2017-9 t.-9 t.-9 t.73 t.-
2016--11 t.-11 t.82 t.-
2015--6 t.-6 t.93 t.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2019

UNIPHARMA ApS: The 2018 annual report is outJun 28, 2019

UNIPHARMA ApS has published its annual report for 2018. Revenue came to DKK -10,140, and the net result was DKK -10,140.

About UNIPHARMA ApS

UNIPHARMA ApS was a Danish company of the type Anpartsselskab based in København K, founded in 1985. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company is owned by Ebba Dorrit Reumert and Ebba Dorrit Reumert. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity amounted to DKK -124,033.